These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32267794)

  • 21. [Current use of anti-hemostatics in ischemic cardiopathy].
    Bolao IG; Alegría E; Iglesias I; Velasco S; Fidalgo ML; Gómez JA; Huelmos A
    Rev Med Univ Navarra; 1990; 34(4):219-26. PubMed ID: 2152748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ischemic heart disease (coronary thrombolysis).
    Kanmatsuse K; Nagao K; Kikushima K; Shioiri K
    Intern Med; 1998 Feb; 37(2):203-5. PubMed ID: 9550610
    [No Abstract]   [Full Text] [Related]  

  • 23. Confusion in reperfusion. Problems in the clinical development of antithrombotic drugs.
    Catella-Lawson F; FitzGerald GA
    Circulation; 1997 Feb; 95(4):793-5. PubMed ID: 9054731
    [No Abstract]   [Full Text] [Related]  

  • 24. Potent antithrombotic treatments in Asian vs. non-Asian patients.
    Goto S; Goto S
    Eur Heart J; 2022 Oct; 43(37):3553-3555. PubMed ID: 35920146
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk factors and clinical outcomes in chronic coronary and peripheral artery disease: An analysis of the randomized, double-blind COMPASS trial.
    Vanassche T; Verhamme P; Anand SS; Shestakovska O; Fox KA; Bhatt DL; Avezum A; Alings M; Aboyans V; Maggioni AP; Widimsky P; Berkowitz SD; Yusuf S; Connolly SJ; Eikelboom JW; Bosch J
    Eur J Prev Cardiol; 2020 Feb; 27(3):296-307. PubMed ID: 31615291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute ischemic heart disease.
    Granger CB; Skene A
    Am Heart J; 2000 Apr; 139(4):S189-92. PubMed ID: 10740129
    [No Abstract]   [Full Text] [Related]  

  • 27. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
    Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
    Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fifty years of experience with antithrombotic therapy in cardiac disease. A 1996 approach based on pathogenesis and risk.
    Freudenberger RS; Fuster V
    Mt Sinai J Med; 1996; 63(5-6):342-58. PubMed ID: 8898540
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antithrombotic therapy in lower extremity arterial disease].
    Franzese M; Coscioni E; Scalise M; Gerardi D; Giugliano G; Esposito G; Stabile E
    G Ital Cardiol (Rome); 2019 Nov; 20(11):632-640. PubMed ID: 31697270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antithrombotic treatment after peripheral arterial surgery].
    Halbritter K; Bötticher G; Hoffmann RT; Weiss N
    Dtsch Med Wochenschr; 2014 Apr; 139(14):680-3. PubMed ID: 24668426
    [No Abstract]   [Full Text] [Related]  

  • 31. Ischaemic heart disease: antithrombotic treatment and new therapeutic targets.
    Crea F
    Eur Heart J; 2023 Jan; 44(4):239-242. PubMed ID: 36680421
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-invasive diagnosis, antithrombotic treatment, and invasive management of ischaemic heart disease.
    Crea F
    Eur Heart J; 2022 Sep; 43(33):3087-3091. PubMed ID: 36044989
    [No Abstract]   [Full Text] [Related]  

  • 33. Features of Antithrombotic Therapy in Patients with Multifocal Arterial Disease.
    Grachev VG; Vedenskaya SS; Smolenskaya OG
    Kardiologiia; 2021 Mar; 61(3):87-95. PubMed ID: 33849424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current status of activation markers in ischemic heart disease: markers of coagulation activation.
    Merlini PA; Ardissino D
    Thromb Haemost; 1997 Jul; 78(1):276-9. PubMed ID: 9198166
    [No Abstract]   [Full Text] [Related]  

  • 35. International workshop on antithrombotic therapy for acute coronary syndromes. May 9-10, 1996, Como, Italy.
    Van de Werf F
    Circulation; 1996 Aug; 94(4):593. PubMed ID: 8772670
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of activation of blood coagulation during acute coronary ischemic syndromes: beyond aspirin and heparin.
    Bates SM; Weitz JI
    Cardiovasc Res; 1999 Feb; 41(2):418-32. PubMed ID: 10341841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic Therapy in Lower Extremity Artery Disease.
    Vrsalovic M; Aboyans V
    Curr Vasc Pharmacol; 2020; 18(3):215-222. PubMed ID: 30727898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Routine invasive versus ischemia-guided strategy in patients with acute inferior ST-elevation myocardial infarction who received fibrinolytic therapy: a prospective randomized controlled pilot trial.
    Abdul-Rahman S; Nammas W; Gamal A; Adel A; Zaki T
    J Invasive Cardiol; 2011 Aug; 23(8):316-21. PubMed ID: 21828392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antithrombotic therapy in patients with peripheral artery diseases].
    Svetlikov AV; Sapelkin SV; Ishpulaeva LÉ; Gorbunov GN
    Angiol Sosud Khir; 2018; 24(3):13-17. PubMed ID: 30321141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sulodexide in conservative treatment of peripheral arterial diseases].
    Kuznetsov MR; Kosykh IV; Yu TV; Kuznetsova VF; Magnitsky IA
    Angiol Sosud Khir; 2015; 21(4):45-51. PubMed ID: 26824094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.